erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
the daily californian covers the city of berkeley and the campus in unparalleled detail, all while training the future of the journalism industry.
.